International Research Journal of Innovations in Engineering and Technology - IRJIET International Open Access, Monthly, Peer Reviewed, Reputed Journal ISSN (online): 2581-3048

Impact Factor (2025): 6.9

DOI Prefix: 10.47001/IRJIET

A Critical Review of the effect of Omega-3 Poly-Unsaturated Fatty Acids (PUFAs) on Coronary Heart Disease (CHD) and CHD Mortality

Abstract

This study is a critical review to ascertain whether Omega-3 (Poly Unsaturated Fatty Acids) PUFAs can help reduce the risk of Coronary Heart disease (CHD) and (CHD) mortality. Omega-3 PUFAs (Poly Unsaturated Fatty Acids) are supplements regularly recommended globally to equalise essential body nutrients and to maintain or improve health. The review captured Mediterranean diets, fatty fish and heart disease, Omega-3 supplements, Clinical Evidence, Positive Clinical Studies, Negative Clinical Outcomes, Net Benefit of Clinical Evidence, the evaluation of the advantages Omega-3 PUFAs on CVD risk factors, especially on CHD and the explanation of the differences in clinical studies. The omega-supplements was found to have been used for different medical problems such as pulmonary, psychiatric, dermatologic, gastrointestinal, renal, rheumatic, and metabolic conditions, they have also commonly been used to prevent or reduce both primary and secondary cardiovascular diseases, particularly coronary heart disease. Many epidemiological studies, as well as extensive randomised clinical (RCTs), indicate that average dosage omega-3 PUFAs substantially minimise the dangers of coronary artery disease (CHD). Based on scientific evidence, it was recommended that patients with CHD, those with or at risk of CHD should take the right dose of omega-3 PUFAs. Much higher doses are required to decrease triglyceride levels. Nonetheless, recent RCTs raise questions about the function of omega-3 PUFAs in CHD treatment. The review also analysed the RCTs and systematic evidence of omega-3 PUFAs to have a clear understanding of the present role of omega-3 PUFAs in reducing or preventing the risk of CHD and CHD mortality.

Country : Nigeria

1 Obi Olor Patience2 Ishiekwen Bridget Ushang3 Ekpenyong Edom Itam

  1. Department of Home Economics, School of Vocational and Technical Education, Cross River State College of Education, Akamkpa-Nigeria
  2. Department of Home Economics, School of Vocational and Technical Education, Cross River State College of Education, Akamkpa-Nigeria
  3. Department of Home Economics, School of Vocational and Technical Education, Cross River State College of Education, Akamkpa-Nigeria

IRJIET, Volume 8, Issue 5, May 2024 pp. 27-35

doi.org/10.47001/IRJIET/2024.805005

Full Paper
Download

References

  1. Abdelhamid, A.S., Martin, N., Bridges, C., Brainard, J.S., Wang, X., Brown, T.J., Hanson, S., Jimoh, O.F., Ajabnoor, S.M., Deane, K.H. and Song, F. (2018). Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. The Cochrane database of systematic reviews, 7, CD012345-CD012345.
  2. Aggarwal, M., Aggarwal, B. and Rao, J. (2017). Integrative medicine for cardiovascular disease and prevention. Medical Clinics, 101(5), 895-923.
  3. Akbaraly, T., Würtz, P., Singh-Manoux, A., Shipley, M.J., Haapakoski, R., Lehto, M., Desrumaux, C., Kähönen, M., Lehtimäki, T., Mikkilä, V. and Hingorani, A. (2018). Association of circulating metabolites with healthy diet and risk of cardiovascular disease: analysis of two cohort studies. Scientific reports, 8(1), 8620-8622.
  4. Arca, M., Borghi, C., Pontremoli, R., De Ferrari, G.M., Colivicchi, F., Desideri, G. and Temporelli, P.L. (2017). Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention. Nutrition, Metabolism and Cardiovascular Diseases.
  5. Archibong, J. E, (2020) Female Suicide Bombers in Boko Haram Insurgency: Victims or Perpetrators. International Journal of World Policy and Development Studies. Vol 6, Issue 2.
  6. Aung, T., Halsey, J., Kromhout, D., Gerstein, H.C., Marchioli, R., Tavazzi, L., Geleijnse, J.M., Rauch, B., Ness, A., Galan, P. and Chew, E.Y. (2018). Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: a meta-analysis of 10 trials involving 77 917 individuals. JAMA cardiology, 3(3), 225-234.
  7. Bird, J.K., Calder, P. and Eggersdorfer, M. (2018). The role of n-3 long-chain polyunsaturated fatty acids in cardiovascular disease prevention, and interactions with statins. Nutrients.
  8. Blondeau, N. (2016). The nutraceutical potential of omega-3 alpha-linolenic acid in reducing the consequences of stroke. Biochimie, 120, 49-55.
  9. Bonilla, I.M., Nishijima, Y., Vargas-Pinto, P., Baine, S.H., Sridhar, A., Li, C., Billman, G.E. and Carnes, C.A. (2016). Chronic omega-3 polyunsaturated fatty acid treatment variably affects cellular repolarisation in a healed post-MI arrhythmia model. Frontiers in physiology, 7, 225.
  10. Chowdhury, R., Warnakula, S., Kunutsor, S., Crowe, F., Ward, H.A., Johnson, L., Franco, O.H., Butterworth, A.S., Forouhi, N.G., Thompson, S.G. and Khaw, K.T. (2014). Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Annals of internal medicine, 160(6), 398-406.
  11. Calder, P.C. (2015). Functional roles of fatty acids and their effects on human health. Journal of Parenteral and Enteral Nutrition, 39, 18S-32S.
  12. Chen, G.C., Yang, J., Eggersdorfer, M., Zhang, W. and Qin, L.Q. (2016). N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis. Scientific reports, 6, 28165.
  13. Chilton, F.H., Dutta, R., Reynolds, L.M., Sergeant, S., Mathias, R.A. and Seeds, M.C. (2017). Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized Supplementation Approaches for the Prevention and Management of Human Diseases. Nutrients, 9(11), 1165.
  14. Colussi, G., Catena, C., Novello, M., Bertin, N. and Sechi, L.A., (2017). Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes. Nutrition, Metabolism and Cardiovascular Diseases, 27(3), pp.191-200.
  15. Davis, C., Bryan, J., Hodgson, J. and Murphy, K. (2015). Definition of the Mediterranean diet; a literature review. Nutrients, 7(11), 9139-9153.
  16. Del Gobbo, L.C., Imamura, F., Aslibekyan, S., Marklund, M., Virtanen, J.K., Wennberg, M., Yakoob, M.Y., Chiuve, S.E., Dela Cruz, L., Frazier-Wood, A.C. and Fretts, A.M. (2016). Ω-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies. JAMA internal medicine, 176(8), 1155-1166.
  17. D'ascoli, T.A., Mursu, J., Voutilainen, S., Kauhanen, J., Tuomainen, T.P. and Virtanen, J.K. (2016). Association between serum long-chain omega-3 polyunsaturated fatty acids and cognitive performance in elderly men and women: The Kuopio Ischaemic Heart Disease Risk Factor Study. European journal of clinical nutrition, 70(8), 970.
  18. Eckel, R.H., Jakicic, J.M., Ard, J.D., De Jesus, J.M., Miller, N.H., Hubbard, V.S., Lee, I.M., Lichtenstein, A.H., Loria, C.M., Millen, B.E. and Nonas, C.A. (2014). 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 63(25 Part B), 2960-2984.
  19. Feguri, G.R., de Lima, P.R.L., de Cerqueira Borges, D., Toledo, L.R., Batista, L.N., e Silva, T.C., Segri, N.J. and de Aguilar-Nascimento, J.E. (2017). Preoperative carbohydrate load and intraoperatively infused omega-3 polyunsaturated fatty acids positively impact nosocomial morbidity after coronary artery bypass grafting: a double-blind controlled randomised trial. Nutrition Journal, 16(1), 24-26.
  20. Forouhi, N.G., Krauss, R.M., Taubes, G. and Willett, W. (2018). Dietary fat and cardio-metabolic health: evidence, controversies, and consensus for guidance. BMJ, 361, 2139.
  21. Freeman, A.M., Morris, P.B., Barnard, N., Esselstyn, C.B., Ros, E., Agatston, A., Devries, S., O’Keefe, J., Miller, M., Ornish, D. and Williams, K. (2017). Trending cardiovascular nutrition controversies. Journal of the American College of Cardiology, 69(9), 1172-1187.
  22. Hamley, S. (2017). The effect of replacing saturated fat with mostly n-6 polyunsaturated fat on coronary heart disease: a meta-analysis of randomised controlled trials. Nutrition Journal, 16(1), 30-36.
  23. Kakoti, B.B., Hernandez-Ontiveros, D.G., Kataki, M.S., Shah, K., Pathak, Y. and Panguluri, S.K. (2015). Resveratrol and omega-3 fatty acid: its implications in cardiovascular diseases. Frontiers in cardiovascular medicine, 2, 38-39.
  24. Kones, R., Howell, S. and Rumana, U. (2017). N-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: Principles, Practices, Pitfalls, and Promises-A Contemporary Review. Medical Principles and Practice, 26(6), 497-508.
  25. Lentjes, M.A., Keogh, R.H., Welch, A.A., Mulligan, A.A.,Luben, R.N., Wareham, N.J. andKhaw, K.T. (2017). Longitudinal associations between marine omega-3 supplement users and coronary heart disease in a UK population-based cohort. BMJ Open, 7(10), 017471.
  26. Li, X.Y., Hao, L., Liu, Y.H., Chen, C.Y., Pai, V.J. and Kang, J.X., (2017). Protection against fine particle-induced pulmonary and systemic inflammation by omega-3 polyunsaturated fatty acids. BiochimicaetBiophysicaActa (BBA)-General Subjects, 1861(3), pp.577-584.
  27. Maehre, H.K., Jensen, I.J., Elvevoll, E.O. and Eilertsen, K.E., (2015). ω-3 Fatty acids and cardiovascular diseases: effects, mechanisms and dietary relevance. International journal of molecular sciences, 16(9), pp.22636-22661.
  28. Maki, K.C., Palacios, O.M., Bell, M. and Toth, P.P., (2017). Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps. Journal of clinical lipidology, 11(5), pp.1152-1160.
  29. Micha, R., Peñalvo, J.L., Cudhea, F., Imamura, F., Rehm, C.D. and Mozaffarian, D., (2017). Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. Jama, 317(9), pp.912-924.
  30. Molfino, A., Amabile, M.I., Monti, M. and Muscaritoli, M., (2017). Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Pro-resolving, or Both. Oxidative medicine and cellular longevity, 2017.
  31. Monahan, K.D., Feehan, R.P., Blaha, C. and McLaughlin, D.J., (2015). Effect of omega‐3 polyunsaturated fatty acid supplementation on central arterial stiffness and arterial wave reflections in young and older healthy adults. Physiological reports, 3(6).
  32. Nestel, P., Clifton, P., Colquhoun, D., Noakes, M., Mori, T.A., Sullivan, D. and Thomas, B., (2015). Indications for omega-3 long-chain polyunsaturated fatty acid in the prevention and treatment of cardiovascular disease. Heart, Lung and Circulation, 24(8), pp.769-779.
  33. Nettleton, J.A., von Schacky, C., Brouwer, I.A. and Koletzko, B., (2017). International Society for the Study of Fatty Acids and Lipids 2016 Debate: For Science-Based Dietary Guidelines on Fats, Meta-Analysis and Systematic Reviews Are Decisive. Annals of Nutrition and Metabolism, 71(1-2), pp.26-30.
  34. O'Connell, T.D., Block, R.C., Huang, S.P. and Shearer, G.C., (2017). ω3 - polyunsaturated fatty acids for heart failure: effects of dose on efficacy and novel signalling through free fatty acid receptor 4. Journal of molecular and cellular cardiology, 103, pp.74-92.
  35. Orsavova, J., Misurcova, L., Ambrozova, J.V., Vicha, R. and Mlcek, J., (2015). Fatty acids composition of vegetable oils and its contribution to dietary energy intake and dependence of cardiovascular mortality on dietary intake of fatty acids. International journal of molecular sciences, 16(6), pp.12871-12890.
  36. Papanikolaou, Y., Brooks, J., Reider, C. and Fulgoni, V.L., (2014). US adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003–2008. Nutrition Journal, 13(1), p.31.
  37. Paoli, A., Moro, T., Bosco, G., Bianco, A., Grimaldi, K.A., Camporesi, E. and Mangar, D., (2015). Effects of n-3 polyunsaturated fatty acids (ω-3) supplementation on some cardiovascular risk factors with a ketogenic Mediterranean diet. Marine Drugs, 13(2), pp.996-1009.
  38. Patel, A.R., Lecerf, J.M., Schenker, S. and Dewettinck, K., (2016). The contribution of modern margarine and fat spreads to dietary fat intake. Comprehensive Reviews in Food Science and Food Safety, 15(3), pp.633-645.
  39. Rhee, J.J., Kim, E., Buring, J.E. and Kurth, T., (2017). Fish consumption, omega-3 fatty acids, and risk of cardiovascular disease. American journal of preventive medicine, 52(1), pp.10-19.
  40. Sacks, F.M., Lichtenstein, A.H., Wu, J.H., Appel, L.J., Creager, M.A., Kris-Etherton, P.M., Miller, M., Rimm, E.B., Rudel, L.L., Robinson, J.G. and Stone, N.J., (2017). Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation, 136(3), pp.e1-e23.
  41. Schunck, W.H., Konkel, A., Fischer, R. and Weylandt, K.H., (2017). Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases. Pharmacology & Therapeutics.
  42. Sekikawa, A., Miura, K., Lee, S., Fujiyoshi, A., Edmundowicz, D., Kadowaki, T., Evans, R.W., Kadowaki, S., Sutton-Tyrrell, K., Okamura, T. and Bertolet, M., (2014). Long-chain n-3 polyunsaturated fatty acids and incidence rate of coronary artery calcification in Japanese men in Japan and white men in the USA: population based prospective cohort study. Heart, 100(7), pp.569-573.
  43. Siscovick, D.S., Barringer, T.A., Fretts, A.M., Wu, J.H., Lichtenstein, A.H., Costello, R.B., Kris-Etherton, P.M., Jacobson, T.A., Engler, M.B., Alger, H.M. and Appel, L.J., (2017). Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease. Circulation, 135(15), pp.e867-e884.
  44. Stark, K.D., Van Elswyk, M.E., Higgins, M.R., Weatherford, C.A. and Salem, N., (2016). Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the bloodstream of healthy adults. Progress in lipid research, 63, pp.132-152.
  45. Thuppal, S.V., Von Schacky, C., Harris, W.S., Sherif, K.D., Denby, N., Steinbaum, S.R., Haycock, B. and Bailey, R.L., (2017). Discrepancy between Knowledge and Perceptions of Dietary Omega-3 Fatty Acid Intake Compared with the Omega-3 Index. Nutrients, 9(9), p.930.
  46. Tortosa-Caparrós, E., Navas-Carrillo, D., Marín, F. and Orenes-Piñero, E., (2017). Anti-Inflammatory effects of omega-3 and omega-6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome. Critical reviews in food science and nutrition, 57(16), pp.3421-3429.
  47. Veenstra, J., Kalsbeek, A., Westra, J., Disselkoen, C., E Smith, C. and Tintle, N., (2017). Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study. Nutrients, 9(8), p.900.
  48. Virtanen, J.K., Wu, J.H., Voutilainen, S., Mursu, J. and Tuomainen, T.P., (2018). Serum n–6 polyunsaturated fatty acids and risk of death: the Kuopio Ischaemic Heart Disease Risk Factor Study. The American journal of clinical nutrition, 107(3), pp.427-435.
  49. Watanabe, Y. and Tatsuno, I., (2017). Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future. Expert review of clinical pharmacology, 10(8), pp.865-873.
  50. Wang, D.D. and Hu, F.B., (2017). Dietary fat and risk of cardiovascular disease: recent controversies and advances. Annual review of nutrition, 37, pp.423-446.
  51. Wang, D.D., Li, Y., Chiuve, S.E., Stampfer, M.J., Manson, J.E., Rimm, E.B., Willett, W.C. and Hu, F.B., (2016). Association of specific dietary fats with total and cause-specific mortality. JAMA internal medicine, 176(8), pp.1134-1145.
  52. Wang, Q., Afshin, A., Yakoob, M.Y., Singh, G.M., Rehm, C.D., Khatibzadeh, S., Micha, R., Shi, P., Mozaffarian, D., Mozaffarian, D. and Micha, R., (2016). Impact of nonoptimal intakes of saturated, polyunsaturated, and trans- fat on global burdens of coronary heart disease. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 5(1).
  53. Widmer, R.J., Flammer, A.J., Lerman, L.O. and Lerman, A., (2015). The Mediterranean diet, its components, and cardiovascular disease. The American journal of medicine, 128(3), pp.229-238.
  54. Weylandt, K.H., Serini, S., Chen, Y.Q., Su, H.M., Lim, K., Cittadini, A. and Calviello, G., (2015). Omega-3 polyunsaturated fatty acids: the way forward in times of mixed evidence. BioMed research international, 2015.
  55. Yagi, S., Fukuda, D., Aihara, K.I., Akaike, M., Shimabukuro, M. and Sata, M., (2017). N-3 polyunsaturated fatty acids: Promising nutrients for preventing cardiovascular disease. Journal of atherosclerosis and thrombosis, 24(10), pp.999-1010.
  56. Zendedel, A., Habib, P., Dang, J., Lammerding, L., Hoffmann, S., Beyer, C. and Slowik, A., (2015). Omega-3 polyunsaturated fatty acids ameliorate neuro-inflammation and mitigate ischemic stroke damage through interactions with astrocytes and microglia. Journal of Neuroimmunology, 278, pp.200-211.

Copyright @ 2026-2017 IRJIET. All Right Reserved.

Developed by Byzero Technologies